Bioinformatics--from genomes to drugs

• Record Nr.: UNINA9910877648203321
• Pubbl/distr/stampa: [Place of publication not identified], : Wiley VCH, 2002
• ISBN: 1-280-55858-X; 9786610558582; 3-527-60148-1
• Descrizione fisica: 1 online resource (640 pages)
• Collana: Methods and Principles in Medicinal Chemistry ; ; v.Vol. 14
• Disciplina: 572.80285
• Soggetti: Genetics; Biology; Science; Genetic Techniques; Chemicals and Drugs; Genomics; Research; Pharmaceutical Preparations; Sequence Analysis; Computational Biology; Natural Science Disciplines; Biological Science Disciplines; Investigative Techniques; Analytical, Diagnostic and Therapeutic Techniques and Equipment; Disciplines and Occupations; Biophysics; Health & Biological Sciences
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Bibliographic Level Mode of Issuance: Monograph
• Nota di contenuto: v. I. Basic technologies -- v. II. Applications.
• Sommario/riassunto: Bioinformatics - the use of computers to retrieve, process, analyse and simulate biological information - promises to revolutionize the process ; of drug discovery and development. This book provides a broad, application-oriented overview of this technology. Contributions by internationally renowned specialists in the field afford a detailed insight into single bioinformatics components and algorithmic methods. In addition, the state-of-the-art in bioinformatics is evaluated equally from a global view by introducing real application scenarios such as genome projects that require the use of a whole set of bioinformatics tools. The profound knowledge on bioinformatics presented here not only enables readers to go beyond a mere push-button approach to using bioinformatics software and interpreting the data generated appropriately. It is also essential to assess the potential and limitations of today's bioinformatics software and future challenges.; Directed to all those involved in the use or development of new bioinformatics tools - scientists and managers from the fields of molecular biotechnology, pharmaceutics, and medicinal chemistry - this book will lead one step further on the way to rational drug design.